✦ LIBER ✦

W1255 Durability of Infliximab in Crohn's Disease Patients Treated with Maintenance Infusions Beyond One Year

✍ Scribed by Gonzaga, Jason E.; Issa, Mazen; Skaros, Susan; Knox, Joshua F.; Emmons, Jeanne; Beaulieu, Dawn B.; Lemke, Kathryn; Ananthakrishnan, Ashwin N.; Binion, David G.

Book ID: 122583748
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 161 KB
Volume: 134
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)63106-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of antibodies to infliximab on in

Effect of antibodies to infliximab on infusion reaction and clinical response in patients with fistulizing Crohn's disease receiving maintenance treatment with infliximab

✍ Wagner, Carrie; Ford, Joyce; Marsters, Paul; Travers, Suzanne; Bao, Weihang; Dev 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB

M1707 One Hour Infliximab Infusion Can R

M1707 One Hour Infliximab Infusion Can Replace Two Hour Infusion in Maintenance Treatment of Crohns Disease Without Shortcomings, in Patients Treated for Up to Three Years

✍ Befrits, Ragnar; Malmström, Linda; Forsell, Anette; Bark, Lars-Åke; Blomquist, L 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

The impact of infliximab infusion reacti

The impact of infliximab infusion reactions on long-term outcomes in patients with Crohn’s disease

✍ A. C. MOSS; N. FERNANDEZ-BECKER; K. JO KIM; D. CURY; A. S. CHEIFETZ 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Maintenance of remission using long-term

Maintenance of remission using long-term treatment with infliximab in patients with crohn's disease: An experience up to three years

✍ L. Grossi; G. De Berardinis; M. spezzaferro; D. Coraggio; L. Marzio 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Autoregressive cross-lagged models of IM

Autoregressive cross-lagged models of IMPACT-III and Pediatric Crohn's Disease Activity indexes during one year infliximab therapy in pediatric patients with Crohn's disease

✍ Szabó, Dolóresz; Kökönyei, Gyöngyi; Arató, András; Dezsőfi, Antal; Molnár, Krisz 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 961 KB

Sustained improvement of health-related

Sustained improvement of health-related quality of life in Crohn's disease patients treated with infliximab and azathioprine for 4 years

✍ Francesc Casellas; Luis Rodrigo; Pilar Niño; Carmen Pantiga; Sabino Riestra; Jua 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

## Background: Infliximab induces remission and improves the health-related quality of life (hrqol) of patients with refractory or fistulous crohn's disease (cd). however, little information is available as to whether its effect on hrqol is sustained over time. the objective was to measure the hrqo